Clinical Management of Check for Glomerular Diseases

被引:2
作者
Orr, Patty [1 ]
Shank, Bettina Cobb [1 ]
Hickson, Shondell [1 ]
Cooke, Jennifer [1 ]
机构
[1] Austin Peay State Univ, Sch Nursing, POB 4658, Clarksville, TN 37044 USA
关键词
Glomerulosclerosis; Focal segmental glomerulosclerosis; Diabetic nephropathy; Membranous nephropathy; Nephrotic syndrome; MEMBRANOUS NEPHROPATHY; RISK;
D O I
10.1016/j.cnur.2018.07.006
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Progressive glomerular damage can occur as a result of various etiologic factors including infections, medications, diseases, and autoimmune disorders. This article discusses the clinical management of the leading conditions associated with glomerular disease, including glomerulosclerosis, diabetic nephropathy, focal segmental glomerulosclerosis, and membranous nephropathy. Glomerular damage and disease progression may lead to end stage renal disease. Clinical management is individualized, as based on causative factors and clinical manifestations, with the overall goal of limiting glomerular damage. Collaborative and comprehensive care is imperative to improving patient outcomes.
引用
收藏
页码:551 / +
页数:18
相关论文
共 50 条
  • [41] Primary and secondary glomerular diseases
    Birck, R.
    Banas, B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (14) : 703 - 705
  • [42] Complement catalyzing glomerular diseases
    Zipfel, Peter F.
    Wiech, Thorsten
    Grone, Hermann-Josef
    Skerka, Christine
    CELL AND TISSUE RESEARCH, 2021, 385 (02) : 355 - 370
  • [43] Con: Biomarkers in glomerular diseases: putting the cart before the wheel?
    De Vriese, An S.
    Fervenza, Fernando C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (06) : 885 - 890
  • [44] Hemicentin 1 influences podocyte dynamic changes in glomerular diseases
    Toffoli, Barbara
    Zennaro, Cristina
    Winkler, Carine
    Attianese, Greta Maria Paola Giordano
    Bernardi, Stella
    Carraro, Michele
    Gilardi, Federica
    Desvergne, Beatrice
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 314 (06) : F1154 - F1165
  • [45] Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways
    Bomback, Andrew S.
    Markowitz, Glen S.
    Appel, Gerald B.
    KIDNEY INTERNATIONAL REPORTS, 2016, 1 (03): : 148 - 155
  • [46] Clinical advances in immunotherapy for immune-mediated glomerular diseases
    Tang, Bihui
    Yang, Xiao
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4091 - 4105
  • [47] Epidemiology of glomerular diseases in a Colombian population
    Rodelo-Ceballos, Joaquin
    Chavez-Gomez, Wilson Fernando
    Taborda-Murillo, Alejandra
    Arias, Luis Fernando
    REVISTA ESPANOLA DE PATOLOGIA, 2025, 58 (03):
  • [48] Targeting APRIL in the treatment of glomerular diseases
    Cheung, Chee Kay
    Barratt, Jonathan
    Lafayette, Richard
    Liew, Adrian
    Suzuki, Yusuke
    Tesar, Vladimir
    Trimarchi, Hernan
    Wong, Muh Geot
    Zhang, Hong
    V. Rizk, Dana
    KIDNEY INTERNATIONAL, 2024, 106 (05) : 806 - 818
  • [49] Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches
    Windpessl, Martin
    Odler, Balazs
    Bajema, Ingeborg M.
    Geetha, Duvuru
    Saemann, Marcus
    Lee, Jiwon M.
    Vaglio, Augusto
    Kronbichler, Andreas
    SEMINARS IN NEPHROLOGY, 2023, 43 (04)
  • [50] Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation
    Jhaveri, Kenar D.
    Shah, Hitesh H.
    Patel, Chinmay
    Kadiyala, Aditya
    Stokes, Michael B.
    Radhakrishnan, Jai
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (01) : 48 - 55